SCHEMBL5036896

SCHEMBL5036896

Cc1cn([C@@]2(C3O[C@H](CO)[C@@H](O)[C@H]3O)C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O

nearest known ligand 0.44

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TK1 P04183 4/20 0.41
PYGM P11217 3/20 0.39
TK2 O00142 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
ALB P02768 1/20 0.38
POLB P06746 1/20 0.38
ADRA1A P35348 1/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9060459 1.00 TK1 (0.41) TK1PYGMTK2ALDH1A1LMNA
SCHEMBL7619980 0.89 TK2 (0.41) TK1TK2ALB
SCHEMBL29276434 0.89 TK1 (0.50) TK1POLB
SCHEMBL7027956 0.89 TK1 (0.39) TK1ALDH1A1LMNAALBBLM
SCHEMBL5698865 0.89 TK1 (0.39) TK1ALDH1A1LMNAALBBLM
SCHEMBL29474410 0.89 TK1 (0.39) TK1ALDH1A1LMNAALBBLM
SCHEMBL7033423 0.89 TK1 (0.39) TK1ALDH1A1LMNAALBBLM
SCHEMBL29088052 0.87 TK1 (0.39) TK1ALDH1A1LMNAALBBLM
SCHEMBL29763091 0.87 TK1 (0.39) TK1ALDH1A1LMNAALBBLM
SCHEMBL31051631 0.86 TK1 (0.42) TK1LMNAALBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529363-A RNA-guided clearance of herpes simplex virus type I and other related human herpesviruses 天普大学-联邦高等教育系统 2023-08-01 CN disclosed
CN-107980062-B Oligonucleotide compounds for targeting huntingtin mRNA 马萨诸塞大学 2022-11-25 CN disclosed
CN-107949424-B TAT-induced CRISPR/endonuclease-based gene editing 天普大学-联邦高等教育系统 2022-03-01 CN disclosed
CN-111526884-A Use of specific siRNA against protein S in the treatment of haemophilia 伯尔尼大学 2020-08-11 CN disclosed
EP-1639121-A4 SYNTHESIS OF BETA -L-2-DEOXY NUCLEOSIDES IDENIX CAYMAN LTD (KY) 2008-04-16 EP disclosed
EP-1639121-A2 SYNTHESIS OF BETA -L-2-DEOXY NUCLEOSIDES Idenix (Cayman) Limited (KY) 2006-03-29 EP disclosed
WO-2005003374-A2 SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES IDENIX (CAYMAN) LIMITED (KY) 2005-01-13 WO disclosed